Mein Warenkorb

ICAM-1

ICAM-1 Molekülinformation

Englischer NameIntercellular adhesion molecule-1Anzahl der inverkehr gebrachten Arzneimittel2
Anzahl der klinischen Arzneimittel4Target-AliasIntercellular Adhesion Molecule 1,Cell Surface Glycoprotein P3.58,Major group rhinovirus receptor,Human Rhinovirus Receptor,CD54 Antigen,P3.58,CD54,BB2,Intercellular Adhesion Molecule-1,ICAM1,ICAM-1,Intercellular Adhesion Molecule 1 (CD54), Human Rhinovirus Receptor,Epididymis Secretory Sperm Binding Protein
Höchste Forschungs- und EntwicklungsphaseApproved
Englischer NameIntercellular adhesion molecule-1
Target-AliasIntercellular Adhesion Molecule 1,Cell Surface Glycoprotein P3.58,Major group rhinovirus receptor,Human Rhinovirus Receptor,CD54 Antigen,P3.58,CD54,BB2,Intercellular Adhesion Molecule-1,ICAM1,ICAM-1,Intercellular Adhesion Molecule 1 (CD54), Human Rhinovirus Receptor,Epididymis Secretory Sperm Binding Protein
Anzahl der inverkehr gebrachten Arzneimittel2
Anzahl der klinischen Arzneimittel4
Höchste Forschungs- und EntwicklungsphaseApproved

ICAM-1 Produktliste

  • Attribut

    Protein (4)

  • Produktbibliothek

    Online (4)

  • Spezies

    Human (3)Mouse (1)

  • Etikett

    Fc Tag (1)His Tag (1)His Tag & Avi Tag (2)

  • Marker

    Unconjugated (2)Biotin-labeled (2)

ICAM-1 Molekülhintergrund

Inter-Cellular Adhesion Molecule 1 (ICAM-1) is also known as Cluster of Differentiation 54 (CD54), is a member of the immunoglobulin superfamily, and is a cell surface glycoprotein which is typically expressed in low concentrations on endothelial cells and cells of the immune system. The protein encoded by this gene is a type of intercellular adhesion molecule continuously present in low concentrations in the membranes of leukocytes and endothelial cells. Upon cytokine stimulation, the concentrations greatly increase. ICAM-1 can be induced by interleukin-1 (IL-1) and tumor necrosis factor alpha (TNFα) and is expressed by the vascular endothelium, macrophages, and lymphocytes. ICAM-1 is a ligand for LFA-1 (integrin), a receptor found on leukocytes. When activated, leukocytes bind to endothelial cells via ICAM-1/LFA-1 and then transmigrate into tissues. ICAM-1 has been implicated in subarachnoid hemorrhage (SAH). Levels of ICAM-1 are shown to be significantly elevated in patients with SAH over control subjects in many studies. ICAM-1 expressed by respiratory epithelial cells is also the binding site for rhinovirus, the causative agent of most common colds.

ICAM-1 Molekülalias

ICAM1,BB2,CD54,P3.58

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
CinainuPhase 3 ClinicalLegacy Healthcare (Switzerland) SaAlopecia Areata
Details
GebasaxturevV-937; CVA-21Phase 2 ClinicalViralytics LtdBreast Neoplasms; Head and Neck Neoplasms; Melanoma; Neoplasm Metastasis; Prostatic Neoplasms; Urinary Bladder Neoplasms
Details
AIC-100AIC-100Phase 1 ClinicalAffyimmune Therapeutics Inc, National Cancer InstituteOncocytic cell carcinoma of the thyroid; Thyroid Carcinoma, Anaplastic
Details
68Ga-ICAM-1pepPhase 1 ClinicalBeijing Cancer HospitalNeoplasms
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
Tocopherol acetateDSE-9912ApprovedNational Institute Of Diabetes And Digestive And Kidney DiseasesEphynal, Aquasol EJapanVitamin E Deficiency; Diabetic Retinopathy; Atherosclerosis; Intermittent Claudication; Venous Thromboembolism; ThrombosisEisai Co Ltd1951-09-01Atherosclerosis; Diabetic Retinopathy; Intermittent Claudication; Metabolic Dysfunction-Associated Steatotic Liver Disease; Thrombosis; Venous Thromboembolism; Vitamin E Deficiency
Details
Ascorbic Acid/Biotin/Cholecalciferol/Cyanocobalamin/Dexpanthenol/Folic acid/Niacinamide/Pyridoxine/Riboflavin/Thiamine/Tocopherol Acetate/Vitamin A/Vitamin KApprovedSandoz Canada IncInfuvite PediatricUnited StatesAvitaminosisSandoz Canada Inc2001-02-21Avitaminosis
Details
  • Molekülinformation
  • Produktliste
  • Inverkehr gebrachte Arzneimittelinformation
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns